0001193125-20-263395.txt : 20201104 0001193125-20-263395.hdr.sgml : 20201104 20201005085836 ACCESSION NUMBER: 0001193125-20-263395 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20201005 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Iterum Therapeutics plc CENTRAL INDEX KEY: 0001659323 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: BLOCK 2 FLOOR 3, HARCOURT CENTRE STREET 2: HARCOURT STREET CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: (872) 225-6077 MAIL ADDRESS: STREET 1: BLOCK 2 FLOOR 3, HARCOURT CENTRE STREET 2: HARCOURT STREET CITY: DUBLIN STATE: L2 ZIP: 2 FORMER COMPANY: FORMER CONFORMED NAME: Iterum Therapeutics Ltd DATE OF NAME CHANGE: 20151124 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Iterum Therapeutics US Ltd CENTRAL INDEX KEY: 0001800794 IRS NUMBER: 475472711 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 200 S. WACKER DRIVE STREET 2: SUITE 2550 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 312-778-6070 MAIL ADDRESS: STREET 1: 200 S. WACKER DRIVE STREET 2: SUITE 2550 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Iterum Therapeutics US Holding Ltd CENTRAL INDEX KEY: 0001800799 IRS NUMBER: 824384195 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 200 S. WACKER DRIVE STREET 2: SUITE 2550 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 312-778-6070 MAIL ADDRESS: STREET 1: 200 S. WACKER DRIVE STREET 2: SUITE 2550 CITY: CHICAGO STATE: IL ZIP: 60606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Iterum Therapeutics International Ltd CENTRAL INDEX KEY: 0001800801 IRS NUMBER: 981283147 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: BLOCK 2 FLOOR 3 HARCOURT CENTRE STREET 2: HARCOURT STREET CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: 353-1-903-8920 MAIL ADDRESS: STREET 1: BLOCK 2 FLOOR 3 HARCOURT CENTRE STREET 2: HARCOURT STREET CITY: DUBLIN STATE: L2 ZIP: 2 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Iterum Therapeutics Bermuda Ltd CENTRAL INDEX KEY: 0001800802 IRS NUMBER: 981517508 STATE OF INCORPORATION: D0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM 11 BUSINESS PHONE: 312-778-6070 MAIL ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM 11 CORRESP 1 filename1.htm CORRESP

October 5, 2020

VIA EDGAR SUBMISSION

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE

Washington, DC 20549

Attention: James Young

 

  Re:

Iterum Therapeutics plc

      

Iterum Therapeutics Bermuda Limited

      

Iterum Therapeutics International Limited

      

Iterum Therapeutics US Limited

      

Iterum Therapeutics US Holding Limited

      

Registration Statement on Form S-1

      

File No. 333-248956

      

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Iterum Therapeutics plc, Iterum Therapeutics Bermuda Limited, Iterum Therapeutics International Limited, Iterum Therapeutics US Limited and Iterum Therapeutics US Holding Limited (collectively, the “Registrants”) hereby request acceleration of the effective date of the Registration Statement on Form S-1 (File No. 333-248956), as amended (the “Registration Statement”), so that it may become effective at 4:30 p.m., Eastern time, on October 6, 2020, or as soon as practicable thereafter.

Very truly yours,
ITERUM THERAPEUTICS PLC
By:   /s/ Corey N. Fishman
  Name: Corey N. Fishman
  Title: Chief Executive Officer
ITERUM THERAPEUTICS BERMUDA LIMITED
By:   /s/ Louise Barrett
  Name: Louise Barrett
  Title: Director
ITERUM THERAPEUTICS INTERNATIONAL LIMITED
By:   /s/ Louise Barrett
  Name: Louise Barrett
  Title: Director
ITERUM THERAPEUTICS US LIMITED
By:   /s/ Corey N. Fishman
  Name: Corey N. Fishman
  Title: Chief Executive Officer
ITERUM THERAPEUTICS US HOLDING LIMITED
By:   /s/ Corey N. Fishman
  Name: Corey N. Fishman
  Title: Chief Executive Officer

 

-2-